Curaleaf provides the retail and wholesale of cannabis products in the United States and globally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities.
It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway.
Additionally, it operates a medical cannabis clinic and holds a pharmacy license. The company serves the medical and adult-use cannabis markets through retail and wholesale channels. The company is based in Stamford, Connecticut.
Curaleaf Holdings, Inc. is a leading cannabis company that provides retail and wholesale cannabis products in the United States and globally. The company operates licensed cultivation facilities and pharma-grade cannabis processing and manufacturing facilities. It supplies cannabis on a wholesale basis to several international markets, including Australia, New Zealand, the United Kingdom, and various European countries such as Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden, and Norway. Additionally, Curaleaf operates a medical cannabis clinic and holds a pharmacy license. The company serves both the medical and adult-use cannabis markets through its retail and wholesale channels.
Where is Curaleaf Holdings (CURLF) listed and in what currency?
Curaleaf Holdings, Inc. is traded on the OTC Markets under the ticker symbol CURLF, specifically on the OTCPK (OTC Pink) exchange. The company's stock is denominated in US Dollars (USD). As an OTC-listed security, it is available for trading in the United States and may have different liquidity and reporting requirements compared to major exchanges like the NYSE or NASDAQ.
What sector and industry does Curaleaf Holdings (CURLF) operate in?
Curaleaf Holdings, Inc. is classified under the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. This classification reflects the company's focus on producing and distributing cannabis products, which are considered specialty pharmaceuticals in many jurisdictions. As a drug manufacturer, Curaleaf engages in the cultivation, processing, and distribution of cannabis for both medical and adult-use purposes, positioning it within the broader pharmaceutical and healthcare landscape.
Where is Curaleaf Holdings headquartered and what markets does it serve?
Curaleaf Holdings, Inc. is headquartered in Stamford, Connecticut, United States. The company serves both domestic and international markets. Domestically, it operates across the United States, providing cannabis products through retail and wholesale channels for medical and adult-use customers. Internationally, Curaleaf supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom, and several European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden, and Norway. The company also operates a medical cannabis clinic and holds a pharmacy license, further expanding its reach in the healthcare sector.
How does Curaleaf Holdings (CURLF) generate revenue?
Curaleaf Holdings generates revenue primarily through the retail and wholesale distribution of cannabis products. The company operates licensed cultivation facilities where it grows cannabis, as well as pharma-grade processing and manufacturing facilities that produce a range of cannabis products. These products are sold through its own retail stores and wholesale channels to other dispensaries and businesses. Curaleaf serves both the medical cannabis market, where patients require prescriptions, and the adult-use market, where cannabis is legal for recreational consumption. Additionally, the company generates revenue from its medical cannabis clinic and pharmacy license, providing healthcare services and dispensing medications. International wholesale sales to countries such as Germany, the UK, and Australia also contribute to its revenue stream.